“…is an acute transforming, replication-defective retrovirus that primarily induces non-thymic lymphomas of the pre-B cell phenotype (Abelson and Rabstein, 1970;Prekumar et al, 1975;Boss et al, 1979). A-MuLV has also been shown, however, to induce a variety of hemopoietic tumors including plasmacytomas (Potter et al, 19731, myelomonocytic leukemias (Rashke et al, 1978;Hines and Gragowski, 1983), T-cell lymphomas (Cook, 19821, and mastocytomas (Mendoza and Metzger, 1976;Risser et al, 1978). In addition, A-MuLV can transform both hemopoietic cells and fibroblasts in vitro (Ftosenberg et al, 1975;Scher and Siegler, 1975).…”